Stroke incidence in adults aged 20–54 nearly doubled from 1993–1994 to 2020, driven largely by ischemic stroke, while 30-day fatality declined, according to new research.
|Articles|March 1, 2006
Thanks for the Memories
Author(s)Mohammed M. Basha, MD
Each time I see a patient, I note on the chart personal events in his or her life--such as "going on a cruise" or "attending grandson's graduation"--in addition to the clinical findings.
Advertisement
Each time I see a patient, I note on the chart personal events in his or her life--such as "going on a cruise" or "attending grandson's graduation"--in addition to the clinical findings. When the patient returns, I bring up the event I jotted down. This usually brings back pleasant memories, and patients appreciate that I follow events in their lives.
--Mohammed M. Basha, MD
Gainesville, Fla
Advertisement
Related to this article
The FDA has approved insulin efsitora alfa-gobe (Onswik) for adults with type 2 diabetes.
New research links type 2 diabetes and genetic risk to MASLD cirrhosis before 50, warning age-based fibrosis scores can miss severe disease.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Lumateperone reduced acute mania symptoms by day 3 in a phase 3 bipolar 1 trial, according to Johnson & Johnson.
Endocrine Society statement highlights key research gaps on obesity drugs—who benefits, long-term dosing, safety, and measuring success beyond weight loss.
Finerenone wins FDA clearance for type 1 diabetes–related CKD, lowering albuminuria in FINE-ONE and opening a long-awaited treatment path.
Advertisement
Advertisement
Trending on Patient Care Online
1
GLP-1 RAs for Weight Management: A Primary Care Approach to Risk and Monitoring
2
FDA Approves Insulin Efsitora Alfa-Gobe for Adults With Type 2 Diabetes
3
Stroke Incidence Nearly Doubled Among Adults Younger Than 55 Over 3 Decades
4
Safety, Dosing, and Drug Interactions for Dextromethorphan-Bupropion in Agitation
5